Skip to main content
Home
Issues
2024
November 2024 Vol 17, Payers' Guide to FDA Updates
2023
December 2023 Vol 16, Payers' Guide to FDA Updates
September 2023 Vol 16, Payers' Guide to FDA Updates
June 2023 - Vol 16 No 1
Issue Archive
Topics
Conference Correspondent
ESMO 2024 - Small Cell Lung Cancer
EHA 2024 – Wrap-Up: Myelodysplastic Syndrome
ASCO 2024 – Wrap-Up: Myelodysplastic Syndrome
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Subscribe
Home
Issues
2024
November 2024 Vol 17, Payers' Guide to FDA Updates
2023
December 2023 Vol 16, Payers' Guide to FDA Updates
September 2023 Vol 16, Payers' Guide to FDA Updates
June 2023 - Vol 16 No 1
Issue Archive
Topics
Conference Correspondent
ESMO 2024 - Small Cell Lung Cancer
EHA 2024 – Wrap-Up: Myelodysplastic Syndrome
ASCO 2024 – Wrap-Up: Myelodysplastic Syndrome
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Prostate Cancer
Prostate Cancer
Agent that Targets Heat Shock Protein Shows Activity in Castration-Resistant Prostate Cancer
Wayne Kuznar
Read More
Prostate Cancer
Abiraterone Before Chemotherapy a Successful Strategy in Prostate Cancer
Wayne Kuznar
Read More
Prostate Cancer
Enzalutamide Extends Survival, Improves QOL in Advanced Prostate Cancer
Wayne Kuznar
Read More
Prostate Cancer
Cabozantinib Shows Dramatic Effects on Bone Metastases in Advanced Prostate Cancer
Wayne Kuznar
Read More
Prostate Cancer
Initial Treatment of Prostate Cancer in Medicare Moving Toward High-Cost Technologies
Read More
Prostate Cancer
New Treatment Options for Castration-Resistant Prostate Cancer
Read More
1
2
3
Page 3 of 3
Results 21 - 26 of 26
